Israel Research Cannabis Tracker
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

View only
 
ABCDEFGHIJKLMN
1
Israel Tracker- Updated 7.24.19
2
TitleStatusStudy ResultsConditionsInterventionsSponsor/CollaboratorsPhasesEnrollmentFunded BysTypeLast Update PostedLocationsResults
3
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.CompletedNo Results Available1- Cancer Patients During Chemotherapy Treatment|2- Use of Cannabis Comparing to Control Without Cannabis UseDrug: cannabisRambam Health Care CampusNot Applicable100OtherInterventionalMay 8, 2017Oncology Institute, Rambam Health Care Campus, Haifa, Israel
4
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa PatientsRecruitingNo Results AvailableRetinitis Pigmentosa|Retinal Degeneration|CannabisDrug: cannabisHadassah Medical Organization|Hebrew University of JerusalemEarly Phase 150OtherInterventionalAugust 2, 2018Hadassah Medical Center, Jerusalem, Israel
5
Effectiveness of Cannabis in the Treatment of Tinnitus PatientsWithdrawnNo Results AvailableTinnitusDrug: Cannabis|Drug: PlaceboWolfson Medical CenterPhase 10OtherInterventionalDecember 28, 2016Wolfson Medical Centre, Holon, Israel
6
Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study)
Not yet recruiting
No Results AvailableProtein-Energy Malnutrition|Hemodialysis|Appetite DisordersDrug: Cannabis oil|Drug: Placebo/ Regular OilAssaf-Harofeh Medical Center|Tikun OlamPhase 340OtherInterventionalSeptember 11, 2018Asaf ha Rofeh, MC, Zrifin, Israel
7
Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult VolunteersRecruitingNo Results AvailableHealthy SubjectsDrug: OWCP Orally Disintegrating Tablet|Drug: SativexOne World Cannabis Ltd.Phase 116IndustryInterventionalMay 3, 2019Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (isr), Israel
8
The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients
Unknown status
No Results AvailableSpasticity|DystoniaDrug: Avidekel oil|Drug: Enriched Avidekel oilWolfson Medical CenterPhase 240OtherInterventionalAugust 18, 2015Dr. Lubov Blumkin, Holon, Israel
9
Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia
Unknown status
No Results AvailableChronic Cannabis Users|Healthy SubjectsProcedure: Magnetoencephalograph (MEG)|Behavioral: Cambridge Neuropsychological Test Automated Battery (CANTAB).|Behavioral: Experimental: Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative Syndrome Scale (PANSS)Shalvata Mental Health CenterNot Applicable115OtherInterventionalJanuary 2, 2012Bar-Ilan University, Givat Shmuel, Israel
10
Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
Not yet recruiting
No Results AvailableHidradenitis SuppurativaDrug: Cannabis oil|Drug: PlaceboTO PharmaceuticalsPhase 240IndustryInterventionalApril 29, 2019Haemek Hospital, Afula, Israel
11
Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel
Unknown status
No Results AvailableCannabis Dependence|Psychostimulant DependenceDrug: RisperidoneTel-Aviv Sourasky Medical CenterNot Applicable100OtherInterventionalJanuary 13, 2012Sourasky Medical center, Tel Aviv, Israel
12
The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of MarijuanaCompletedNo Results AvailableMarijuana DependenceDrug: Tetra Hydro Cannabinol (THC)Tel-Aviv Sourasky Medical Center|Hadassah Medical OrganizationNot Applicable12OtherInterventionalMay 7, 2008Department of Nuclear Medicine, Tel Aviv, Israel
13
Cannabis for Inflammatory Bowel Disease
Unknown status
No Results AvailableCrohn's Disease|Ulcerative ColitisDrug: smoking of cannabis|Drug: smoking cigarettes with placeboMeir Medical CenterPhase 1|Phase 220OtherInterventionalDecember 16, 2011
Meir hospital, Kefar Saba, Israel|Meir Medical center, Kfar Saba, Israel
14
The Effect of Cannabis on Dementia Related Agitation and AggressionRecruitingNo Results AvailableAgitation Related to DementiaDrug: Cannabis|Drug: Placebo oilTO PharmaceuticalsPhase 260IndustryInterventionalApril 23, 2019Laniado Hospital, Netanya, Israel
15
Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
Unknown status
No Results AvailableMarijuana DependenceDrug: EscitalopramTel-Aviv Sourasky Medical CenterNot Applicable40OtherInterventionalApril 1, 2008Sourasky Medical Center, Tel Aviv, Israel
16
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
Unknown status
No Results AvailablePain, Postoperative|Postoperative Nausea and Vomiting|AnxietyDrug: Tetrahydrocannabinol|Drug: Acetaminophen|Drug: Midazolam|Drug: Dummy oromucosal sprayHadassah Medical Organization|GW Pharmaceuticals Ltd.Phase 2|Phase 3200Other|IndustryInterventionalMarch 24, 2016
Hasassah - Hebrew University Ein Kerem Medical Center, Jerusalem, Israel
17
Cannabinoids Effects on the Pain Modulation System
Active, not recruiting
No Results AvailableNeuropathic PainDrug: Cannabis oilTel-Aviv Sourasky Medical CenterNot Applicable40OtherInterventionalJune 14, 2018Pain Institute, Tel Aviv Medical Center, Tel Aviv, Israel
18
The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients
Unknown status
No Results AvailableAlcohol-dependenceDrug: NaltrexoneTel-Aviv Sourasky Medical Center|Ministry of Health, IsraelNot Applicable24OtherInterventionalMarch 21, 2012Dept. of Nuclear Medicine, TASMC, Tel Aviv, Israel
19
Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction
Unknown status
No Results AvailableMarijuana AbuseDevice: H-Coil deep TMSShalvata Mental Health CenterPhase 1|Phase 2nullOtherInterventionalOctober 12, 2007Shalvata Mental Health Center, Hod-HaSharon, Israel
20
A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy VolunteersCompletedNo Results AvailableSafety Study for Future Treatment of PsoriasisDrug: OWC MGC cream|Drug: OWC Control CreamOne World Cannabis Ltd.Phase 126IndustryInterventionalMarch 13, 2019Sheba Medical Center, Ramat Gan, Israel
21
Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)CompletedNo Results AvailablePainDrug: Sativex buccal spray|Drug: CBD-THC-Piperine-PNL capsuleHadassah Medical OrganizationPhase 112OtherInterventionalMarch 24, 2016Hadassah medical organization, Jerusalem, Israel
22
5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: PNL-THC:CBD soft gelatin capsule|Drug: Sativex|Drug: CBD hard capsule dose 1|Drug: P-PNL-THC:CBD soft gelatin capsule|Drug: CBD hard capsule dose 2PhytoTech Therapeutics, Ltd.Phase 115IndustryInterventionalSeptember 20, 2017
Clinical Research Center (CRC)- Souraskey Medical center, Tel Aviv, Israel
23
Combined THC and CBD Drops for Treatment of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: THC 5mg/ml and CBS 50mg/ml|Drug: PlaceboMeir Medical CenterPhase 1|Phase 250OtherInterventionalMarch 8, 2019Meir Hospital, Kfar Saba, Israel
24
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer PatientsCompletedNo Results AvailableCancer Cachexia|Atypical Anorexia NervosaOther: Cannabics capsulesCannabics Pharmaceuticals Inc.Not Applicable24IndustryInterventionalApril 10, 2018Rambam MC, Haifa, Israel
25
Cannabidiol for Inflammatory Bowel DiseaseCompletedNo Results AvailableCrohn's Disease|Ulcerative ColitisDrug: cannabidiol|Drug: placebo in dropsMeir Medical CenterPhase 1|Phase 220OtherInterventionalApril 16, 2013Sapir Medical center Meir Hospital, Kefar Saba, Israel
26
Cytokine Production of Colonic Tissue From IBD Patients
Unknown status
No Results AvailableInflammatory Bowel DiseaseOther: no intervention in patients treatment, only biopsy takenMeir Medical CenterNot Applicable50OtherInterventionalOctober 25, 2016Gastroenterology institute Meir Hospital, Kfar Saba, Israel
27
Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
Unknown status
No Results AvailablePosttraumatic Stress DisordersDrug: Tetrahydrocannabinol|Other: PlaceboHadassah Medical OrganizationPhase 470OtherInterventionalOctober 30, 2012Hadassah Medical Organization, Jerusalem, Israel
28
Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Unknown status
No Results AvailableAcute-graft-versus-host DiseaseDrug: Cannabidiol|Drug: Methylprednisolone|Drug: Calcineurin inhibitormoshe yeshurun|Rabin Medical CenterPhase 210OtherInterventionalMarch 19, 2015
Davidof Cancer Center, Beilinson hospital, Rabin medical center, Petach Tikva, Israel
29
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced CancerCompletedHas ResultsPain|Advanced CancerDrug: Nabiximols|Drug: Placebo (GA-0034)GW Pharmaceuticals Ltd.|Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3406IndustryInterventionalApril 23, 2018
East Melbourne, Australia|Parkville, Australia|Shumen, Bulgaria|Varna, Bulgaria|Vratsa, Bulgaria|Lunen, Germany|Stadtroda, Germany|Wetzlar, Germany|Budapest, Hungary|Deszk, Hungary|Komárom, Hungary|Nyíregyháza, Hungary|Szikszó, Hungary|Bangalore, India|Jaipur, India|Pune, India|Ashkelon, Israel|Beer Sheva, Israel|Haifa, Israel|Jerusalem, Israel|Ramat Gan, Israel|Zerifin, Israel|Garbagnate Milanese, Italy|Piacenza, Italy|Torino, Italy|Klaipeda, Lithuania|Siauliai, Lithuania|Vilnius, Lithuania|Bydgoszcz, Poland|Czeladź, Poland|Gdansk, Poland|Gliwice, Poland|Klodzko, Poland|Opole, Poland|Ostrowiec Swietokrzyski, Poland|Poznan, Poland|Warszawa, Poland|Warszawa, Poland|Wloclawek, Poland|Alba Iulia, Romania|Baia Mare, Romania|Braila, Romania|Bucuresti, Romania|Focșani, Romania|Oradea, Romania|Satu Mare, Romania|Sibiu, Romania|Suceava, Romania|Cadiz, Spain|Granada, Spain|Madrid, Spain|Salamanca, Spain|Sevilla, Spain|Changhua City, Taiwan|Taichung, Taiwan|Tainan City, Taiwan|Taipei, Taiwan|Taipei, Taiwan|Taipei, Taiwan|Taipei, Taiwan|Bury Saint Edmunds, United Kingdom|Edinburgh, United Kingdom|Glasgow, United Kingdom|Manchester, United Kingdom|Norwich, United Kingdom
30
Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related PainCompletedHas ResultsPain|Advanced CancerDrug: NabiximolsGW Pharmaceuticals Ltd.|Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3660IndustryInterventionalApril 23, 2018
Phoenix, Arizona, United States|Phoenix, Arizona, United States|El Cajon, California, United States|Gilroy, California, United States|Glendale, California, United States|Santa Rosa, California, United States|Clearwater, Florida, United States|Daytona Beach, Florida, United States|Holiday, Florida, United States|Jacksonville, Florida, United States|Lynn Haven, Florida, United States|Miami, Florida, United States|Stuart, Florida, United States|Tampa, Florida, United States|Winter Park, Florida, United States|Marietta, Georgia, United States|Newnan, Georgia, United States|Stockbridge, Georgia, United States|Woodlawn, Illinois, United States|Ashland, Kentucky, United States|Bossier City, Louisiana, United States|Shreveport, Louisiana, United States|Saint Louis Park, Minnesota, United States|Kansas City, Missouri, United States|Missoula, Montana, United States|Berlin, New Jersey, United States|New York, New York, United States|New York, New York, United States|Flat Rock, North Carolina, United States|Winston-Salem, North Carolina, United States|Cleveland, Ohio, United States|Philadelphia, Pennsylvania, United States|Houston, Texas, United States|Laredo, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Lacey, Washington, United States|Parkville, Australia|Bruxelles, Belgium|Gabrovo, Bulgaria|Varna, Bulgaria|Vratsa, Bulgaria|Benešov, Czechia|Jablonec Nad Nisou, Czechia|Most, Czechia|Nová Ves Pod Pleší, Czechia|Ostrava, Czechia|Plzen, Czechia|Sokolov, Czechia|Teplice, Czechia|České Budějovice, Czechia|České Budějovice, Czechia|Berlin, Germany|Frankfurt, Germany|Jena, Germany|Lunen, Germany|Stadtroda, Germany|Wetzlar, Germany|Wiesbaden, Germany|Deszk, Hungary|Komarom, Hungary|Miskolc, Hungary|Nyíregyháza, Hungary|Szekszard, Hungary|Szikszo, Hungary|Beer Sheva, Israel|Haifa, Israel|Ramat Gan, Israel|Zerifin, Israel|Garbagnate Milanese, Italy|Piacenza, Italy|Torino, Italy|Riga, Latvia|Rēzekne, Latvia|Klaipeda, Lithuania|Siauliai, Lithuania|Vilnius, Lithuania|Chihuahua, Mexico|Distrito Federal, Mexico|Białystok, Poland|Bielsko-Biala, Poland|Bydgoszcz, Poland|Czeladz, Poland|Częstochowa, Poland|Częstochowa, Poland|Działdowo, Poland|Gdansk, Poland|Gliwice, Poland|Klodzko, Poland|Opole, Poland|Ostrowiec Swietokrzyski, Poland|Poznan, Poland|Warszawa, Poland|Warszawa, Poland|Wloclawek, Poland|Ponce, Puerto Rico|San Juan, Puerto Rico|Baia Mare, Romania|Baia Mare, Romania|Braila, Romania|Bucuresti, Romania|Bucuresti, Romania|Cluj-Napoca, Romania|Constanţa, Romania|Craiova, Romania|Focsani, Romania|Iaşi, Romania|Oradea, Romania|Satu Mare, Romania|Sibiu, Romania|Suceava, Romania|Târgovişte, Romania|Granada, Spain|Taichung, Taiwan|Tainan City, Taiwan|Bury Saint Edmunds, United Kingdom|Bury, United Kingdom|Cheltenham, United Kingdom|Crumpsall, United Kingdom|Edinburgh, United Kingdom|Edinburgh, United Kingdom|Gorleston-on-Sea, United Kingdom|Leeds, United Kingdom|Manchester, United Kingdom|Norwich, United Kingdom|Plymouth, United Kingdom|Weston-super-Mare, United Kingdom|Withington, United Kingdom
31
A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 YearsCompletedNo Results AvailableCerebral PalsyDrug: Sativex|Drug: PlaceboGW Research LtdPhase 372IndustryInterventionalMay 17, 2017
Center 14, Prague, Czechia|Center 7, Tel Aviv, Israel|Center 8, Tel Hashomer, Israel|Center 2, Bristol, United Kingdom|Center 6, Cambridge, United Kingdom|Center 10, Exeter, United Kingdom|Center 13, Glasgow, United Kingdom|Center 3, Liverpool, United Kingdom|Center 1, London, United Kingdom|Center 5, London, United Kingdom|Center 12, Norwich, United Kingdom|Center 9, Nottingham, United Kingdom|Center 11, Salisbury, United Kingdom|Center 4, Sheffield, United Kingdom
32
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms
Not yet recruiting
No Results AvailableMultiple SclerosisDrug: PTL201|Drug: Placebo Oral CapsulePhytoTech Therapeutics, Ltd.Phase 270IndustryInterventionalSeptember 28, 2017Sheba medical center, Tel Hashomer, Ramat gan, Israel
33
Tai-chi / Qi-gong in Patients With Patients With Gynecological MalignanciesWithdrawnNo Results AvailableOvarian Cancer|Primary Peritoneal Cancer|Other Gynecological CancersOther: Tai-chi/Qi-gongSheba Medical Center|Tel Aviv UniversityPhase 1|Phase 20OtherInterventionalJune 11, 2015Sheba Hospital, Ramat Gan, Israel
https://clinicaltrials.gov/ct2/show/results/NCT01424566?term=cannabis&recrs=e&rslt=With&map_cntry=IL&rank=1
34
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver DiseaseCompletedHas ResultsHepatitis C, ChronicDrug: eltrombopag|Drug: placeboGlaxoSmithKlinePhase 3759IndustryInterventionalNovember 5, 2013
GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Arcadia, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Lynwood, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, San Diego, California, United States|GSK Investigational Site, San Mateo, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Indianapolis, Indiana, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, New Orleans, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Lebanon, New Hampshire, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Kinston, North Carolina, United States|GSK Investigational Site, Morganton, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Germantown, Tennessee, United States|GSK Investigational Site, Mountain Home, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Seattle, Washington, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Cairns, Queensland, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Clayton, Victoria, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Parkville, Victoria, Australia|GSK Investigational Site, Prahran, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Edmonton, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Hradec Kralove, Czech Republic|GSK Investigational Site, Olomouc, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Cairo, Egypt|GSK Investigational Site, Mansoura, Egypt|GSK Investigational Site, Shebeen El-Kom, Menoufeya, Egypt|GSK Investigational Site, Besançon, France|GSK Investigational Site, Bondy, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Grenoble, France|GSK Investigational Site, Lille, France|GSK Investigational Site, Marseille Cedex 08, France|GSK Investigational Site, Orléans, France|GSK Investigational Site, Paris Cedex 12, France|GSK Investigational Site, Paris Cedex 13, France|GSK Investigational Site, Rouen, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Vandoeuvre Les Nancy, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Rotenburg (Wuemme), Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Oberhausen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Chemnitz, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Rio, Patras, Greece|GSK Investigational Site, Thessaloniki, Greece|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Hyderabad, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Nazareth, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Rehovot, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Daegu, Korea, Republic of|GSK Investigational Site, Pusan, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Raciborz, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Saint-Petersburg, Russian Federation|GSK Investigational Site, Samara, Russian Federation|GSK Investigational Site, St.Peterburg, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Málaga, Spain|GSK Investigational Site, Palma de Mallorca, Spain|GSK Investigational Site, Pontevedra, Spain|GSK Investigational Site, Sabadell (Barcelona), Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Changhua, Taiwan|GSK Investigational Site, Chia-Yi Hsien, Taiwan|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taiyuan Hsien, Taiwan|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kiev, Ukraine|GSK Investigational Site, Vinnitsa, Ukraine
https://clinicaltrials.gov/ct2/show/results/NCT01337089?term=cannabis&recrs=e&rslt=With&map_cntry=IL&rank=2
35
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseCompletedHas ResultsHepatitis C, ChronicDrug: eltrombopag|Drug: placeboGlaxoSmithKlinePhase 3687IndustryInterventionalNovember 5, 2013
GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Gainsville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Orlando, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Ann Arbor, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Valhalla, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Jackson, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Fairfax, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Praha 4, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Besançon, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Marseille, France|GSK Investigational Site, Montpellier, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Pessac Cedex, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Toulouse cedex 9, France|GSK Investigational Site, Toulouse, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Incheon, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Amsterdam, Netherlands|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Mosocow, Russian Federation|GSK Investigational Site, Smolensk, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Granada, Spain|GSK Investigational Site, L'Hospitalet de Llobregat. Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Tainan, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Chiangmai, Thailand|GSK Investigational Site, Khon Kaen, Thailand|GSK Investigational Site, Songkla, Thailand|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Vinnytsia, Ukraine|GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, Plymouth, United Kingdom
36
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related SymptomsNot yet recruitingNo Results AvailableMultiple SclerosisDrug: PTL201|Drug: Placebo Oral CapsulePhytoTech Therapeutics, Ltd.Phase 270IndustryInterventionalSeptember 28, 2017Sheba medical center, Tel Hashomer, Ramat gan, Israel
37
Tai-chi / Qi-gong in Patients With Patients With Gynecological MalignanciesWithdrawnNo Results AvailableOvarian Cancer|Primary Peritoneal Cancer|Other Gynecological CancersOther: Tai-chi/Qi-gongSheba Medical Center|Tel Aviv UniversityPhase 1|Phase 20OtherInterventionalJune 11, 2015Sheba Hospital, Ramat Gan, Israel
38
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver DiseaseCompletedHas ResultsHepatitis C, ChronicDrug: eltrombopag|Drug: placeboGlaxoSmithKlinePhase 3759IndustryInterventionalNovember 5, 2013
GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Arcadia, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Lynwood, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, San Diego, California, United States|GSK Investigational Site, San Mateo, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Indianapolis, Indiana, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, New Orleans, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Lebanon, New Hampshire, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Kinston, North Carolina, United States|GSK Investigational Site, Morganton, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Germantown, Tennessee, United States|GSK Investigational Site, Mountain Home, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Seattle, Washington, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Cairns, Queensland, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Clayton, Victoria, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Parkville, Victoria, Australia|GSK Investigational Site, Prahran, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Edmonton, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Hradec Kralove, Czech Republic|GSK Investigational Site, Olomouc, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Cairo, Egypt|GSK Investigational Site, Mansoura, Egypt|GSK Investigational Site, Shebeen El-Kom, Menoufeya, Egypt|GSK Investigational Site, Besançon, France|GSK Investigational Site, Bondy, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Grenoble, France|GSK Investigational Site, Lille, France|GSK Investigational Site, Marseille Cedex 08, France|GSK Investigational Site, Orléans, France|GSK Investigational Site, Paris Cedex 12, France|GSK Investigational Site, Paris Cedex 13, France|GSK Investigational Site, Rouen, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Vandoeuvre Les Nancy, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Rotenburg (Wuemme), Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Oberhausen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Chemnitz, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Rio, Patras, Greece|GSK Investigational Site, Thessaloniki, Greece|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Hyderabad, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Nazareth, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Rehovot, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Daegu, Korea, Republic of|GSK Investigational Site, Pusan, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Raciborz, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Saint-Petersburg, Russian Federation|GSK Investigational Site, Samara, Russian Federation|GSK Investigational Site, St.Peterburg, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Málaga, Spain|GSK Investigational Site, Palma de Mallorca, Spain|GSK Investigational Site, Pontevedra, Spain|GSK Investigational Site, Sabadell (Barcelona), Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Changhua, Taiwan|GSK Investigational Site, Chia-Yi Hsien, Taiwan|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taiyuan Hsien, Taiwan|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kiev, Ukraine|GSK Investigational Site, Vinnitsa, Ukraine
https://clinicaltrials.gov/ct2/show/results/NCT00516321?term=cannabis&recrs=e&rslt=With&map_cntry=IL&rank=4
39
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver DiseaseCompletedHas ResultsHepatitis C, ChronicDrug: eltrombopag|Drug: placeboGlaxoSmithKlinePhase 3687IndustryInterventionalNovember 5, 2013
GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Gainsville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Orlando, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Ann Arbor, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Valhalla, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Jackson, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Fairfax, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Praha 4, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Besançon, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Marseille, France|GSK Investigational Site, Montpellier, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Pessac Cedex, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Toulouse cedex 9, France|GSK Investigational Site, Toulouse, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Incheon, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Amsterdam, Netherlands|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Mosocow, Russian Federation|GSK Investigational Site, Smolensk, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Granada, Spain|GSK Investigational Site, L'Hospitalet de Llobregat. Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Tainan, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Chiangmai, Thailand|GSK Investigational Site, Khon Kaen, Thailand|GSK Investigational Site, Songkla, Thailand|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Vinnytsia, Ukraine|GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, Plymouth, United Kingdom
40
41
Loading...